Eli Lilly and Company (Ticker: LLY), based in Indianapolis, Indiana, is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare. Specializing in critical therapeutic areas including diabetes, oncology, and neurodegenerative diseases, the company operates in around 125 countries, continually striving to enhance patient outcomes through substantial investments in research and development. With a strategic emphasis on sustainable growth, robust product pipeline advancements, and strategic partnerships, Lilly fortifies its status as a key player in the pharmaceutical industry, committed to advancing modern medicine while driving shareholder value.

NYSE

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

LILLY CORPORATE CENTER, INDIANAPOLIS, IN, UNITED STATES, 46285

December

$923 Billion

$28.7 Billion

50.0

20.6

$5.80

0.57%

0.389